UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 225

Sortiert nach

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Link zum Volltext

Verfügbarkeit prüfen

Human Herpesvirus 6 Genome and Antigen in Acute Multiple Sclerosis Lesions

The Journal of infectious diseases, 2003-05, Vol.187 (9), p.1365-1376

2003

Link zum Volltext

Verfügbarkeit prüfen

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9665), p.732-738

2009

Link zum Volltext

Verfügbarkeit prüfen

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Neurology, 2008-10, Vol.71 (15), p.1134

2008

Link zum Volltext

Verfügbarkeit prüfen

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS

Neurology, 2009-02, Vol.72 (6), p.535

2009

Link zum Volltext

Verfügbarkeit prüfen

Quantitative functional measures in MS: what is a reliable change?

Neurology, 2002-04, Vol.58 (8), p.1294

2002

Link zum Volltext

Verfügbarkeit prüfen

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS

Neurology, 2002-09, Vol.59 (5), p.679

2002

Link zum Volltext

Verfügbarkeit prüfen

Fatigue in multiple sclerosis: current understanding and future directions

Journal of rehabilitation research and development, 2002-03, Vol.39 (2), p.211-224

2002

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS

Neurology, 2007-03, Vol.68 (12), p.939

2007

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of motor fatigue and strength in MS

Neurology, 1999-09, Vol.53 (4), p.743

1999

Link zum Volltext

Verfügbarkeit prüfen

Cognitive fatigue during a test requiring sustained attention: a pilot study

Multiple sclerosis, 2003-10, Vol.9 (5), p.503-508

2003

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

Neurology, 1997-04, Vol.48 (4), p.817

1997

Link zum Volltext

Verfügbarkeit prüfen

Potential Environmental and Host Participants in the Early White Matter Lesion of Adreno-Leukodystrophy: Morphologic Evidence for CD8 Cytotoxic T Cells, Cytolysis of Oligodendrocytes, and CD1-Mediated Lipid Antigen Presentation

Journal of neuropathology and experimental neurology, 2001-10, Vol.60 (10), p.1004-1019

2001

Link zum Volltext

Verfügbarkeit prüfen

An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis

Multiple sclerosis, 2004-10, Vol.10 (5), p.511-520

2004

Link zum Volltext

Verfügbarkeit prüfen

Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial

Multiple sclerosis, 2003-12, Vol.9 (6), p.585-591

2003

Link zum Volltext

Verfügbarkeit prüfen

Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data

Multiple sclerosis, 2008-04, Vol.14 (3), p.370-382

2008

Link zum Volltext

Verfügbarkeit prüfen

Oral and dental infections

1989

Link zum Volltext

Verfügbarkeit prüfen

The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach

Journal of clinical virology, 2000-05, Vol.16 (3), p.159-178

2000

Link zum Volltext

Verfügbarkeit prüfen

The measurement of ambulatory impairment in multiple sclerosis

Neurology, 1997-11, Vol.49 (5), p.1419

1997

Link zum Volltext

Verfügbarkeit prüfen

Sustained-release fampridine consistently improves walking speed and leg strength in multiple sclerosis: a phase 3 trial

Multiple sclerosis, 2008-09, Vol.14, p.S298-S298

2008

Link zum Volltext

Verfügbarkeit prüfen

Infections and MS: clinical trials move to center stage

Neurology, 2002-01, Vol.58 (1), p.7

2002

Link zum Volltext

Verfügbarkeit prüfen

Are quantitative functional measures more sensitive to worsening MS than traditional measures?

Neurology, 2000-12, Vol.55 (12), p.1901

2000

Link zum Volltext

Verfügbarkeit prüfen

Human herpesvirus 6-meningoencephalitis in an hiv patient with progressive multifocal leukoencephalopathy

Acta neuropathologica, 2000-09, Vol.100 (3), p.337-341

2000

Link zum Volltext

Verfügbarkeit prüfen

Conditioning of cyclophosphamide-induced leukopenia in humans

The journal of neuropsychiatry and clinical neurosciences, 1996, Vol.8 (2), p.194-201

1996

Link zum Volltext

Verfügbarkeit prüfen

Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy

Journal of neurovirology, 1999-08, Vol.5 (4), p.363-373

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(172)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(156)
Life Sciences & Biomedicine
(136)
Humans
(103)
Male
(72)
Female
(68)
Biological And Medical Sciences
(60)
Adult
(51)
Medical Sciences
(46)
Middle Aged
(45)
Neurosciences & Neurology
(30)
Animals
(29)
Clinical Neurology
(27)
Aged
(22)
General & Internal Medicine
(21)
Medicine, General & Internal
(21)
Adolescent
(19)
Neurology
(19)
Rats
(16)
Fundamental And Applied Biological Sciences. Psychology
(14)
Social Sciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Human Herpesvirus 6 Genome and Antigen in Acute Multiple Sclerosis Lesions

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS

Quantitative functional measures in MS: what is a reliable change?

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS

Fatigue in multiple sclerosis: current understanding and future directions

Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS

Quantitative assessment of motor fatigue and strength in MS

Cognitive fatigue during a test requiring sustained attention: a pilot study

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

Potential Environmental and Host Participants in the Early White Matter Lesion of Adreno-Leukodystrophy: Morphologic Evidence for CD8 Cytotoxic T Cells, Cytolysis of Oligodendrocytes, and CD1-Mediated Lipid Antigen Presentation

An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis

Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial

Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data

Oral and dental infections

The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach

The measurement of ambulatory impairment in multiple sclerosis

Sustained-release fampridine consistently improves walking speed and leg strength in multiple sclerosis: a phase 3 trial

Infections and MS: clinical trials move to center stage

Are quantitative functional measures more sensitive to worsening MS than traditional measures?

Human herpesvirus 6-meningoencephalitis in an hiv patient with progressive multifocal leukoencephalopathy

Conditioning of cyclophosphamide-induced leukopenia in humans

Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy

Suchergebnisse filtern